Watchlist Price Alert

ZyVersa Therapeutics Inc. (ZVSA)

NASDAQ: ZVSA · Real-Time Price · USD

0.52

0.02 (3.24%)

At close: May 15, 2025, 1:45 PM

ZyVersa Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-9.41M	-98.3M	-14.05M	-8.08M	-12.68M
Depreciation & Amortization	6.93K	10.4K	9.87K	10.4K	10.4K
Stock-Based Compensation	705.57K	1.19M	3.52M	4.14M	3.83M
Other Working Capital	179.31K	194.51K	1.67M	-708.45K	3.71M
Other Non-Cash Items	n/a	95.25M	1.47M	317.83K	288.37K
Deferred Income Tax	6.75K	-9.48M	-745.05K	-441.58K	333.66K
Change in Working Capital	929.88K	2.6M	8.29M	-1.02M	3.11M
Operating Cash Flow	-7.56M	-8.72M	-1.49M	-5.08M	-5.11M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	1.69M
Common Stock Repurchased	n/a	-10.7M	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-1.46M	n/a	5.23M	-126.4K
Financial Cash Flow	5.95M	5.96M	1.87K	5.23M	4.56M
Net Cash Flow	-1.61M	-2.76M	370.74K	153.91K	-549.76K
Free Cash Flow	-7.56M	-8.72M	-1.49M	-5.08M	-5.11M